Methods of purification of heat shock protein-peptide complexes for use as vaccines against cancers and infectious diseases.
Srivastava
P K
PK
Center for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut Health Center, Farmington, USA.
Jaikaria
N S
NS
D000818:Animals; D002135:Calcium-Binding Proteins / Q000302:isolation & purification; D037282:Calreticulin; D019496:Cancer Vaccines; D002460:Cell Line; D002850:Chromatography, Gel / Q000379:methods; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D002852:Chromatography, Ion Exchange / Q000379:methods; D018840:HSP70 Heat-Shock Proteins / Q000302:isolation & purification; D018841:HSP90 Heat-Shock Proteins / Q000302:isolation & purification; D006360:Heat-Shock Proteins / Q000276:immunology* / Q000302:isolation & purification*; D006801:Humans; D007202:Indicators and Reagents; D051379:Mice; D009369:Neoplasms / Q000276:immunology*; D009374:Neoplasms, Experimental / Q000276:immunology; D010455:Peptides / Q000276:immunology*; D051381:Rats; D012261:Ribonucleoproteins / Q000302:isolation & purification; D014614:Vaccines, Synthetic
D002135:Calcium-Binding Proteins; D037282:Calreticulin; D019496:Cancer Vaccines; D018840:HSP70 Heat-Shock Proteins; D018841:HSP90 Heat-Shock Proteins; D006360:Heat-Shock Proteins; D007202:Indicators and Reagents; D010455:Peptides; D012261:Ribonucleoproteins; D014614:Vaccines, Synthetic